ClinicalTrials.gov
public full text
Public Domain
Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
This study compares the safety of the tobramycin solution for inhalation with the tobramycin dry powder formulation, used with a simple inhaler
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis#1046410
- A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis#915333
- An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis#844875
- A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo#1088039
- A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer#900763
Record · ID 873021
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive